---

$1.38

+0.0250 ( +1.85% ) 75.2K

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-26	Sale	-60000.00	Coveney Kevin Michael
2024-02-26	Sale	-50000.00	Facchini Peter J.
2024-02-26	Sale	-100000.00	Tucker Joseph Edward
2023-09-19	Buy	1000.00	PASQUALONE FRANK